The Experimental Therapeutics program members work to find new drug therapies for cancer and to design more effective drugs that specifically target cancer and are less toxic.
The program most closely unites the Cancer Institute’s Drug Discovery Core, a part of the National Center for Natural Products Research at the University of Mississippi, with researchers at UMMC enabling the scientists to find new natural products with anti-cancer properties and test it on specific cancers.
The program unites basic researchers, translational researchers and physicians to more quickly identify and develop new therapies, to make those therapies highly effective and to minimize side effects.
Dr. Shou-Ching Tang, associate director for clinical and translational research, heads the program.
Members of this program search for: